Michael S. Brown, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 3,660 shares at $393.49 ($1.4M) on 2018-09-27, disclosed to the SEC on 2018-09-28.
Open-market sale of $1.4M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $390.23 | 389 | $152K | 10.6% |
| 2 | $390.23 | 389 | $152K | 10.6% |
| 3 | $391.38 | 601 | $235K | 16.4% |
| 4 | $391.38 | 601 | $235K | 16.4% |
| 5 | $392.37 | 410 | $161K | 11.2% |
| 6 | $392.37 | 410 |
| $161K |
| 11.2% |
| 7 | $393.49 | 300 | $118K | 8.2% |
| 8 | $394.43 | 40 | $16K | 1.1% |
| 9 | $395.42 | 260 | $103K | 7.2% |
| 10 | $395.42 | 260 | $103K | 7.2% |
| Total | $392.14 avg | 3,660 | $1.4M | 100% |
| Filing → |
| REGN | SELL | 2024-05-29 | $2.3M | — | Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |